Research Topics
| Herman SuitSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Proton beams to replace photon beams in radical dose treatmentsHerman Suit
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
Acta Oncol 42:800-8. 2003..5 provided there were to be no charge for the original facility and that there were sufficient patients for operating on an extended schedule (6-7 days of 14-16 h) with > or = two gantries and one fixed horizontal beam...
Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjectsHerman Suit
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
Radiat Res 167:12-42. 2007..1 Gy, i.e. dose to tissues distant from the target. The proportionate gain should be greatest for dose decrement to less than 2 Gy...
Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? NoHerman Suit
Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Radiother Oncol 86:148-53. 2008..Evaluate the rationale for the proposals that prior to a wider use of proton radiation therapy there must be supporting data from phase III clinical trials. That is, would less dose to normal tissues be an advantage to the patient?..
Proton vs carbon ion beams in the definitive radiation treatment of cancer patientsHerman Suit
Department of Radiation Oncology, Boston, MA, USA
Radiother Oncol 95:3-22. 2010..The principal differences are LET, low for (1)H and high for (12)C, and a narrower penumbra of (12)C beams. Were (12)C to yield a higher TCP for a defined NTCP than (1)H therapy, would LET, fractionation or penumbra width be the basis?..
A personal philosophy of a radiation oncologistHerman Suit
Department of Radiation Oncology, Harvard Medical School, Boston, MA 02114, USA
Radiother Oncol 100:10-4. 2011..Physicians should view our current best treatment as obsolete and use this as a provocation for active effort to develop superior management strategies...
[Coming technical advances in radiation oncology]Herman Suit
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Z Med Phys 15:215-27. 2005..The impact will be higher tumor control probability and reduced frequency and severity of treatment-related morbidity...
The Gray Lecture 2001: coming technical advances in radiation oncologyHerman Suit
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Int J Radiat Oncol Biol Phys 53:798-809. 2002..To review the current limits on the efficacy of radiotherapy (RT) due to technical factors and to assess the potential for major improvements in technology...
The centenary of the discovery of the Bragg peakAndrew Brown
Seacoast Cancer Center, 789, Central Avenue, Dover, NH 03820, USA
Radiother Oncol 73:265-8. 2004..The accepted view was that ionization would decrease exponentially with depth. This depth dose pattern is the basis for the dose distributional advantage of charged particles relative to photons...
